Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Omri Amirav-Drory
AddedMar 31, 2024
UpdatedMay 31, 2026
Omri Amirav-Drory

Omri Amirav-Drory

Board Member, Mana.bio

CrunchbaseLinkedIn

Omri Amirav-Drory's Career

Mana.bio
Mana.bio

Tel Aviv, Tel Aviv District, IL

Board Member· Board
Light Bio
Light Bio

Mount Horeb, WI, US

Board Member· Board
Pepper Bio
Pepper Bio

Dedham, MA, US

Board Member· Board
ResistanceBio
ResistanceBio

San Carlos, CA, US

Board Member· Board
Talus Bio
Talus Bio

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Omri Amirav-Drory's Career

Mana.bio
Mana.bio
Seed$29.5M2021Tel Aviv, Tel Aviv District, IL
Board Member· Board

Recent news

Mana.bio Announces Strategic Leadership Additions and Upcoming Presentation at ASGCT 2026 Annual MeetingPR Newswire · 2026
Mana.bio Unveils Mina, the World’s First LLM-Powered AI Agent for Lipid NanoparticlesMana.bio · 2025
Israeli biotech startup mana.bio launches AI-fueled programmable drug therapyTechCrunch · 2023

Leadership at Mana.bio

Kira RadinskyKira RadinskyScientific Co-Founder
Avi SchroederAvi SchroederScientific Co-Founder
Yogev DebbiYogev DebbiCo-founder & CEO
Roy NevoRoy NevoCo-Founder
Light Bio
Light Bio

Mount Horeb, WI, US

Board Member· Board
Pepper Bio
Pepper Bio
Seed$6.5M82018Dedham, MA, US
Board Member· Board

Recent news

Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new fundingTechCrunch · 2023

Leadership at Pepper Bio

Jon Hu (Yu)Jon Hu (Yu)Co-Founder
Samantha Dale StrasserSamantha Dale StrasserCo-Founder

Similar to Pepper Bio

PeptilogicsPeptilogicsPittsburgh, PA, USPeptide Therapeuticsest. 2013PeptilogicsPittsburgh, PA, US · est. 2013

Peptilogics: An American biotech firm revolutionizing drug discovery with novel peptide therapeutics.

Series D · $44.1M28
ZielBioZielBioCharlottesville, VA, USDrug Discoveryest. 2011ZielBioCharlottesville, VA, US · est. 2011

ZielBio: An early-stage biotech firm innovating patient outcomes through novel drug discovery.

Series A · $33M13
BioAI HealthBioAI HealthGoffstown, NH, USAI Diagnostics, Biotechest. 2020BioAI HealthGoffstown, NH, US · est. 2020

BioAI Health: Leveraging AI for improved disease diagnosis, therapy response prediction, and clinical trials.

Seed · $3M9
ResistanceBio
ResistanceBio

San Carlos, CA, US

Board Member· Board
Talus Bio
Talus Bio
Series A$11.7M402020Seattle, WA, US
Board Member· Board

Leadership at Talus Bio

Alex FederationAlex FederationFounder
Lorin BrandonLorin BrandonCo-Founder
Tim WhiteTim WhiteCo-Founder
Lindsay PinoLindsay PinoFounder

Similar to Talus Bio

Parallel BioParallel BioCambridge, MA, USDrug Discoveryest. 2021Parallel BioCambridge, MA, US · est. 2021

Parallel Bio: Human immune system platform for drug and vaccine testing.

Seed · $4.6M9
Atavistik BioAtavistik BioCambridge, MA, USDrug Discoveryest. 2021Atavistik BioCambridge, MA, US · est. 2021

Atavistik Bio: Pioneering pre-clinical biotech firm developing first-in-class drug candidates.

Private Equity · $100M36

Omri Amirav-Drory's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailHiroshi MikitaniHiroshi MikitaniBoard Member · RakutenKen KutaragiKen KutaragiBoard Member · RakutenTakashi MitachiTakashi MitachiBoard Member · Rakuten

People Similar to Omri Amirav-Drory

Joel SolomonJoel SolomonBoard Member · Renewal FundsRob HaydenRob HaydenFounder · RenewDaniel OliverDaniel OliverCo-Founder & CEO · Rejuvenate BioStephen LeeStephen LeeCo-Founder · RenewaDavid HoDavid HoCo-Founder · RenBioCameron OwenCameron OwenCo-Founder · Rbio